Transparency & TrustAt Ipsen, we consider transparency to be a key requirement to nurture relations of trust with patients, stakeholders and the general public. Our policy of transparency extends across all aspects of our collaboration with healthcare professionals and organizations and is designed to make sure that the pharmaceutical industry's ethical principles are fully complied with.
Environment, Health, SecurityIpsen's activities require a high level of security and a development strategy that respects the environment. The Group's Environment, Health and Safety (EHS) policy sets out its commitments in this area. It focuses on prevention and is based on ISO 14001 (environment) and OHSAS 18001 (health and safety). This approach is part of a continuous improvement policy to ensure accountability at all levels of the organization.
Ethics & ComplianceOur determination to improve patient health and quality of life demands the highest ethical standards across the entire Group, from research and development through to marketing.
SponsorshipAnnually all payments made by Ipsen to UK healthcare professionals and healthcare organisations during the previous calendar year will be disclosed on a searchable and publicly accessible central database on The Association of the British Pharmaceutical Industry (ABPI) website known as Disclosure UK.
Last update 03/04/2018